Cargando…
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
PURPOSE: Heterozygous mutations in CTLA4 lead to an inborn error of immunity characterized by immune dysregulation and immunodeficiency, known as CTLA-4 insufficiency. Cohort studies on CTLA4 mutation carriers showed a reduced penetrance (around 70%) and variable disease expressivity, suggesting the...
Autores principales: | Krausz, Máté, Mitsuiki, Noriko, Falcone, Valeria, Komp, Johanna, Posadas-Cantera, Sara, Lorenz, Hanns-Martin, Litzman, Jiri, Wolff, Daniel, Kanariou, Maria, Heinkele, Anita, Speckmann, Carsten, Häcker, Georg, Hengel, Hartmut, Gámez-Díaz, Laura, Grimbacher, Bodo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667032/ https://www.ncbi.nlm.nih.gov/pubmed/36405723 http://dx.doi.org/10.3389/fimmu.2022.1011646 |
Ejemplares similares
-
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
por: Krausz, Máté, et al.
Publicado: (2023) -
Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023) -
Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023) -
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
por: Krausz, Máté, et al.
Publicado: (2022) -
Sequencing the B Cell Receptor Repertoires of Antibody-Deficient Individuals With and Without Infection Susceptibility
por: Lim, Yoong Wearn, et al.
Publicado: (2023)